We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.23B
AUM Growth
+$59.4M
Cap. Flow
+$16.2M
Cap. Flow %
1.31%
Top 10 Hldgs %
42.86%
Holding
211
New
11
Increased
78
Reduced
63
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.27M
2
PAYX icon
Paychex
PAYX
+$3.5M
3
SCHW
Charles Schwab
SCHW
+$2.97M
4
EPD icon
Enterprise Products Partners
EPD
+$2.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.36M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$3.22M
2
PNC icon
PNC Financial Services
PNC
+$2.38M
3
NEE icon
NextEra Energy
NEE
+$2.23M
4
VZ icon
Verizon
VZ
+$1.82M
5
STJ
St Jude Medical
STJ
+$1.53M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.24%
2 Healthcare 14.87%
3 Financials 10.21%
4 Technology 9.69%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
1
Walmart Inc
WMT
$893B
$247M 20.1%
10,159,041
-56,478
-0.6% -$1.31M
KO icon
2
Coca-Cola
KO
$353B
$57.2M 4.65%
1,261,802
-21,996
-2% -$994K
XOM icon
3
ExxonMobil
XOM
$615B
$46.9M 3.81%
500,106
-14,159
-3% -$1.25M
BMY icon
4
Bristol-Myers Squibb
BMY
$123B
$43.1M 3.5%
585,796
+88,700
+18% +$6.27M
PG icon
5
Procter & Gamble
PG
$347B
$29.6M 2.41%
349,734
-3,941
-1% -$323K
UPS icon
6
United Parcel Service
UPS
$96.2B
$27.8M 2.26%
257,916
-322
-0.1% -$33.5K
AFL icon
7
Aflac
AFL
$63.2B
$20.9M 1.7%
579,046
-94,400
-14% -$3.22M
JNJ icon
8
Johnson & Johnson
JNJ
$599B
$19.1M 1.55%
157,307
-1,616
-1% -$184K
AAPL icon
9
Apple
AAPL
$4.8T
$18.7M 1.52%
780,932
+20,440
+3% +$508K
META icon
10
Meta Platforms (Facebook)
META
$1.64T
$16.8M 1.37%
147,000
+5,600
+4% +$645K
MSFT icon
11
Microsoft
MSFT
$2.99T
$16.7M 1.36%
326,274
-5,352
-2% -$278K
CL icon
12
Colgate-Palmolive
CL
$73.6B
$15.3M 1.24%
209,090
-927
-0.4% -$66K
PAYX icon
13
Paychex
PAYX
$41B
$14.9M 1.21%
250,422
+65,392
+35% +$3.5M
PEP icon
14
PepsiCo
PEP
$185B
$14.6M 1.19%
138,249
-5,284
-4% -$545K
GE icon
15
GE Aerospace
GE
$354B
$14.3M 1.17%
95,100
-1,518
-2% -$221K
MRK icon
16
Merck
MRK
$307B
$13.3M 1.08%
242,257
+4,245
+2% +$226K
PFE icon
17
Pfizer
PFE
$141B
$12M 0.98%
359,649
-738
-0.2% -$23.6K
ABT icon
18
Abbott
ABT
$177B
$11.6M 0.95%
295,750
-12,200
-4% -$486K
LOW icon
19
Lowe's Companies
LOW
$115B
$11.4M 0.92%
143,556
+6,753
+5% +$522K
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$122B
$11M 0.9%
128,010
+27,323
+27% +$2.36M
AMGN icon
21
Amgen
AMGN
$197B
$10.9M 0.88%
71,400
+10,680
+18% +$1.66M
SBUX icon
22
Starbucks
SBUX
$119B
$10.9M 0.88%
190,110
+515
+0.3% +$29.3K
INTC icon
23
Intel
INTC
$488B
$10.7M 0.87%
325,006
+3,300
+1% +$103K
CSCO icon
24
Cisco
CSCO
$436B
$10.6M 0.86%
370,100
-3,500
-0.9% -$98.3K
MMM icon
25
3M
MMM
$83B
$10.4M 0.84%
70,821
-4,352
-6% -$614K
1
2 3 4 5

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.24B AUM 31.81% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Cullinan Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Cullinan Associates held 211 positions worth $1.23B, up 5.1% from $1.17B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cullinan Associates's Q2 2016 filing shows 11 new, 78 increased, 63 reduced and 10 closed positions. Its largest new stake was Charles Schwab: 104,400 shares worth $2.64M. The largest sale was Aflac, an estimated $3.22M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • Cullinan Associates's largest Q2 2016 buy was Charles Schwab: 104,400 shares worth $2.64M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q2 2016, an estimated $6.27M increase.
  • Cullinan Associates's biggest Q2 2016 reduction was Aflac, cutting an estimated $3.22M.
  • Cullinan Associates fully exited St Jude Medical in Q2 2016, selling an estimated $1.53M.
  • Cullinan Associates's ten largest holdings make up 43% of its $1.23B portfolio in Q2 2016.
  • Cullinan Associates opened 11 new positions and closed 10 in Q2 2016.
  • Cullinan Associates's portfolio value rose 5.1% quarter-over-quarter to $1.23B.

Based on Cullinan Associates's 13F filing for Q2 2016, filed 1 Jul 2016.